:format():fill())
It will be available for eligible people most at risk of complications from shingles.
A 2-dose course of Shingrix® will be available for free for:
people aged 65 years and older
First Nations people aged 50 years and older
immunocompromised people aged 18 years and older with the following medical conditions:
haemopoietic stem cell transplant
solid organ transplant
haematological malignancy
advanced or untreated HIV
Unlike Zostavax®, Shingrix® does not contain any live virus so it can be given to people aged 18 years and over who are immunocompromised.